Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

doc category: deliverables

D3.2 First version on guidance tools on data/sample sharing and use

This deliverable focuses on developing specific guidance to aid projects on data sharing policies and

D1.2 Integrated programme analysis

NEURONET is a Coordination and Support Action (CSA) aiming to support and better integrate projects

D1.3 Map of relevant initiatives and gap analysis v1

This deliverable aimed to map the global research landscape for neurodegenerative diseases to understand where

D2.2 Report #1 on activity of SCB, WGs and TFs

The NEURONET Coordination and Support Action has the main objective of setting up an efficient

D3.4 First version of guidance on standards and practices for protecting data privacy

D3.4 - First version of guidance on standards and practices for protecting data privacy

Neuronet is a Coordination and Support Action (CSA) aiming to support and better integrate projects

D4.2 Public event proceedings and videos – Year 1

D4.2 Public event proceedings and videos - Year 1

NEURONET also organises an annual networking and outreach event in collaboration with the leaders of

D3.3 First version of regulatory/HTA/payer interaction decision tool

This deliverable reports on the development of a Decision Tool aimed at identifying the key

D1.1 Project outreach and analysis package

This deliverable reports on the workflow and processes followed by WP1 to develop a full

D5.1 Initial Data & Knowledge Management Plan

This first deliverable of WP5 CSA Management & Sustainability (D5.1)  constitutes the first version of

D3.1 INKB web platform v1: NEURONET Knowledge Base v1

Deliverable D3.1 describes the design and structure of the NEURONET Knowledge Base, a web platform

Post navigation
Older posts
Newer posts
← Previous Page1 Page2 Page3 Next →

LATEST NEWS

  • Watch interviews with RADAR-CNS researchers and members of its Patient Advisory Board

    8th August 2022
    RADAR-CNS was a Innovative Medicines Initiative (IMI) funded collaborative research project that explored the potentialRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    1st August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • AMYPAD announces Last Patient Out in its Prognostic Study

    15th July 2022
    On the 30 June, the members of the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD)Read More
  • AAIC workshop on fluid biomarkers features EPND partners, Charlotte Teunissen and Henrik Zetterberg

    8th July 2022
    The Alzheimer’s Association International Conference (AAIC), organised annually by the US Alzheimer’s Association, is knownRead More
  • PD-MitoQUANT holds Final Project Meeting in Copenhagen

    7th July 2022
    Time has certainly flown! With the PD-MitoQUANT project formally ending in July 2022, project partnersRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2022 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT